Free press releases distribution network?

Agency / Source: LamdaGen Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Alion and LamdaGen Announce Collaboration to Accelerate Small Molecule Drug Development - Rapid identification of compounds to treat neurodegenerative diseases - Alion-Pharmaceuticals.com / LamdaGen.com
Alion and LamdaGen Announce Collaboration to Accelerate Small Molecule Drug Development

 

PRZOOM - /newswire/ - Menlo Park, CA, United States, 2011/02/22 - Rapid identification of compounds to treat neurodegenerative diseases - Alion-Pharmaceuticals.com / LamdaGen.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Alion Pharmaceuticals and LamdaGen Corporation announced today that the two biotechnology companies have entered into a Strategic Collaboration to identify and characterize small molecule inhibitors for the treatment of neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s Disease, and Neuropathic Pain.

The Collaboration combines Alion’s proprietary computer aided drug design technology and methodologies with LamdaGen’s highly sensitive nano-sensor based bioanalytical systems to accelerate the identification of novel small molecule drug candidates to treat neurologic disorders.

“Recent efforts between our two organizations have led to the validated activity of several Alion compounds directed against targets of therapeutic value in Alzheimer’s disease. With combined use of our respective technologies, we have demonstrated that protein/peptide interactions can be regulated with our small molecule inhibitors. This has important implications for the identification of new therapeutic drugs, which makes this early stage discovery and validation activity very exciting, ” stated Allan Bates, President of Alion.
The companies are in discussion with several pharmaceutical companies regarding the utilization of their integrated discovery technologies for use in specific drug discovery and development programs.

About Alion

Alion Pharmaceuticals (alion-pharmaceuticals.com) is a computational chemistry company employing proprietary CADD and biophysical methodologies to accelerate the discovery and development of small molecule therapeutics.

About LamdaGen

LamdaGen Corporation (lamdagen.com) is a rapidly growing biosensor company utilizing proprietary nano-based metamaterials to facilitate improved testing and analyses for drug discovery and development, as well as diagnostic applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: LamdaGen Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Alion and LamdaGen Announce Collaboration to Accelerate Small Molecule Drug Development

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Nicholas Virca, COO - LamdaGen.com 
650-571-5816 collaboration[.]alion-pharmaceuticals.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any LamdaGen Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From LamdaGen Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  MagLar, Inc.

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today